Nick Speer
Private Equity Investor chez Affinity Equity Partners (HK) Ltd.
Profil
Nick Speer is Managing Partner at Riverside Partners (Australia).
He is also on the board of Avance Clinical Pty Ltd.
He previously held the position of Executive Director at Catalyst Investment Managers Pty Ltd.
He received an undergraduate degree from the University of MelboNick Speer joined the Firm in 2023 and is the Head of Affinity Equity Partners in Australia & New Zealand.
Before joining Affinity, Nick was a Managing Partner and spent nine years at The Riverside Company in Australia, an established mid-market buyout firm headquartered in the US.
Between 2005 and 2014 he was an Executive Director at Catalyst Investment Managers.
He began his career as an investment banker at Caliburn Partnership in Sydney.
Nick holds a Program for Leadership Development degree from Harvard Business School and a Bachelor of Commerce, with honours in Finance from The University of Melbourne.urne.
Postes actifs de Nick Speer
| Sociétés | Poste | Début |
|---|---|---|
Affinity Equity Partners (HK) Ltd.
 Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners (HK) Ltd.(Affinity Equity Partners) is an Independent private equity firm founded in 1998 by Kok Yew Tang. Affinity Equity Partners (HK) Ltd. is headquartered in Korea, Australia, New Zealand, Greater China and Southeast Asia.. | Private Equity Investor | 01/06/2023 |
Anciens postes connus de Nick Speer
| Sociétés | Poste | Fin |
|---|---|---|
| Riverside Partners (Australia) | Private Equity Investor | 01/05/2023 |
Catalyst Investment Managers Pty Ltd.
 Catalyst Investment Managers Pty Ltd. Investment ManagersFinance Catalyst Investment Managers Pty Ltd. (Catalyst Investment) is a private equity firm founded in 1989. The firm is headquartered in Woollahra, New South Wales. | Private Equity Investor | 01/04/2014 |
Avance Clinical Pty Ltd.
 Avance Clinical Pty Ltd. BiotechnologyHealth Technology Avance Clinical Pty Ltd. is a premium full-service CRO that delivers quality clinical trials for international biotechs. Avance Clinical is based in Thebarton, AU, and has subsidiaries in the United States. The Australian company provides fast, agile, and adaptive solution-oriented clinical research services to biotechs in their drug development phases. The CEO of the company is Yvonne Lungershausen. | Directeur/Membre du Conseil | - |
Formation de Nick Speer
| University of Melbourne | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Catalyst Investment Managers Pty Ltd.
Catalyst Investment Managers Pty Ltd. Investment ManagersFinance Catalyst Investment Managers Pty Ltd. (Catalyst Investment) is a private equity firm founded in 1989. The firm is headquartered in Woollahra, New South Wales. | Finance |
Affinity Equity Partners (HK) Ltd.
Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners (HK) Ltd.(Affinity Equity Partners) is an Independent private equity firm founded in 1998 by Kok Yew Tang. Affinity Equity Partners (HK) Ltd. is headquartered in Korea, Australia, New Zealand, Greater China and Southeast Asia.. | Finance |
| Riverside Partners (Australia) | Finance |
Avance Clinical Pty Ltd.
Avance Clinical Pty Ltd. BiotechnologyHealth Technology Avance Clinical Pty Ltd. is a premium full-service CRO that delivers quality clinical trials for international biotechs. Avance Clinical is based in Thebarton, AU, and has subsidiaries in the United States. The Australian company provides fast, agile, and adaptive solution-oriented clinical research services to biotechs in their drug development phases. The CEO of the company is Yvonne Lungershausen. | Health Technology |